MBL Wealth LLC Buys New Shares in Intuitive Surgical, Inc. $ISRG

MBL Wealth LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 384 shares of the medical equipment provider’s stock, valued at approximately $209,000.

A number of other hedge funds also recently made changes to their positions in the stock. Chilton Capital Management LLC boosted its holdings in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at about $26,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at about $30,000. TD Capital Management LLC grew its holdings in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new stake in Intuitive Surgical during the 1st quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.1%

Shares of Intuitive Surgical stock opened at $452.35 on Monday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a market capitalization of $162.16 billion, a price-to-earnings ratio of 63.09, a PEG ratio of 4.74 and a beta of 1.61. The business’s 50 day simple moving average is $463.55 and its 200-day simple moving average is $500.11.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s revenue was up 21.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.78 EPS. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the transaction, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 in the last ninety days. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on ISRG shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Saturday, September 27th. Piper Sandler restated an “overweight” rating and set a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. UBS Group increased their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a report on Wednesday, July 23rd. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Finally, The Goldman Sachs Group decreased their target price on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. Fourteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $594.19.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.